Shang Li
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 7
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 4
- Oncology top 10%
- PARP inhibition in cancer therapy 6
- Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods 6
- Cancer Research top 10%
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases 4
-
- Aquatic Ecosystems and Phytoplankton Dynamics 5
- Co-authors
- Lingyi KongXiaobing WangXiujuan WangJi‐Gang BaiFucheng YinLailiang QuDaining FangDehua Lu
- Journals
- European Journal of Medicinal Chemistry (10 papers)Journal of Medicinal Chemistry (8 papers)The Science of The Total Environment (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Shang Li
80 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 1.0k
- Oncology 368
- Organic Chemistry 352
- Cancer Research 173
- Pharmacology 126
Countries citing papers authored by Shang Li
This map shows the geographic impact of Shang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang Li more than expected).
Fields of papers citing papers by Shang Li
This network shows the impact of papers produced by Shang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang Li. The network helps show where Shang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 27 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 38 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 47 | |
| 15 | 2017 | 7 | |
| 16 | 2016 | 123 | |
| 17 | 2014 | 15 | |
| 18 | 2012 | 25 | |
| 19 | 2011 | 36 | |
| 20 | 1998 | 101 |
About Shang Li
Shang Li is a scholar working on Pharmacology, Oncology and Molecular Biology, having authored 85 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Catalytic C–H Functionalization Methods (6 papers), RNA modifications and cancer (6 papers), PARP inhibition in cancer therapy (6 papers), Aquatic Ecosystems and Phytoplankton Dynamics (5 papers), Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Oncology (368 citations) and Organic Chemistry (352 citations). Shang Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Lingyi Kong, Xiaobing Wang, Xiujuan Wang, Ji‐Gang Bai, Fucheng Yin, Lailiang Qu, Daining Fang, Dehua Lu, Xingchen Liu and Heng Luo. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, The Science of The Total Environment, Organic Letters and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.